case_images: PMC11333830_01
case_images: Drugs' timeline.
case_images: fonc-14-1398055-g001.jpg
case_images: PMC11333830_01_fonc-14-1398055-g001.jpg
case_images: f1
case_images: After four years of sunitinib therapy, further peritoneal disease progression was noted, and regorafenib 160 mg/day (once daily for 3 weeks followed by 1 week off-therapy) was prescribed as a third-line treatment in June 2019 ( Figure 1 ).
case_images: Hemoglobin (A), red blood cells (B) and hematocrit (C) trend.   phlebotomy.
case_images: fonc-14-1398055-g002.jpg
case_images: PMC11333830_01_fonc-14-1398055-g002.jpg
case_images: f2
case_images: Afterwards, the Hb and Hct levels finally returned to normal values. ( Figure 2 ).